Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin

Hideharu Hagiya; Tomohiro Terasaka; Kosuke Kimura; Asuka Satou; Kikuko Asano; Koichi Waseda; Yoshihisa Hanayama; Fumio Otsuka

doi:10.2169/internalmedicine.53.2711

Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin

Hideharu Hagiya, Tomohiro Terasaka, Kosuke Kimura, Asuka Satou, Kikuko Asano, Koichi Waseda, Yoshihisa Hanayama, Fumio Otsuka

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

We herein report a case of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia that was successfully treated with combination therapy consisting of high-dose daptomycin (DAP, 10 mg/kg) and rifampicin. The patient’s condition was complicated with multiple infectious foci, including an iliopsoas abscess and epidural abscess, as well as discitis and spondylitis at the cervical, thoracic and lumbar levels. Monotherapy treatments with vancomycin, linezolid and usual-dose DAP were all ineffective. It has been shown that usual-dose DAP administration may result in the emergence of a resistant strain and treatment failure. We would like to emphasize the importance of high-dose DAP therapy for MRSA bacteremia, a condition with a potentially high mortality rate.

Original language	English
Pages (from-to)	2159-2163
Number of pages	5
Journal	Internal Medicine
Volume	53
Issue number	18
DOIs	https://doi.org/10.2169/internalmedicine.53.2711
Publication status	Published - Sep 1 2014

Keywords

Butyrylcholinesterase (BChE) deficiency
Daptomycin (DAP)
Methicillin-resistant Staphylococcus aureus (MRSA)
Staphylococcus aureus bacteremia (SAB)

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.2169/internalmedicine.53.2711

Fingerprint Dive into the research topics of 'Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin'. Together they form a unique fingerprint.

Cite this

Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin. / Hagiya, Hideharu; Terasaka, Tomohiro; Kimura, Kosuke; Satou, Asuka; Asano, Kikuko; Waseda, Koichi; Hanayama, Yoshihisa ; Otsuka, Fumio.

In: Internal Medicine, Vol. 53, No. 18, 01.09.2014, p. 2159-2163.

Research output: Contribution to journal › Article › peer-review

@article{93bb057483f947a8bed07cd7191a5989,

title = "Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin",

abstract = "We herein report a case of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia that was successfully treated with combination therapy consisting of high-dose daptomycin (DAP, 10 mg/kg) and rifampicin. The patient{\textquoteright}s condition was complicated with multiple infectious foci, including an iliopsoas abscess and epidural abscess, as well as discitis and spondylitis at the cervical, thoracic and lumbar levels. Monotherapy treatments with vancomycin, linezolid and usual-dose DAP were all ineffective. It has been shown that usual-dose DAP administration may result in the emergence of a resistant strain and treatment failure. We would like to emphasize the importance of high-dose DAP therapy for MRSA bacteremia, a condition with a potentially high mortality rate.",

keywords = "Butyrylcholinesterase (BChE) deficiency, Daptomycin (DAP), Methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus aureus bacteremia (SAB)",

author = "Hideharu Hagiya and Tomohiro Terasaka and Kosuke Kimura and Asuka Satou and Kikuko Asano and Koichi Waseda and Yoshihisa Hanayama and Fumio Otsuka",

note = "Publisher Copyright: {\textcopyright} 2014 The Japanese Society of Internal Medicine.",

year = "2014",

month = sep,

day = "1",

doi = "10.2169/internalmedicine.53.2711",

language = "English",

volume = "53",

pages = "2159--2163",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "18",

}

TY - JOUR

T1 - Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin

AU - Hagiya, Hideharu

AU - Terasaka, Tomohiro

AU - Kimura, Kosuke

AU - Satou, Asuka

AU - Asano, Kikuko

AU - Waseda, Koichi

AU - Hanayama, Yoshihisa

AU - Otsuka, Fumio

PY - 2014/9/1

Y1 - 2014/9/1

N2 - We herein report a case of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia that was successfully treated with combination therapy consisting of high-dose daptomycin (DAP, 10 mg/kg) and rifampicin. The patient’s condition was complicated with multiple infectious foci, including an iliopsoas abscess and epidural abscess, as well as discitis and spondylitis at the cervical, thoracic and lumbar levels. Monotherapy treatments with vancomycin, linezolid and usual-dose DAP were all ineffective. It has been shown that usual-dose DAP administration may result in the emergence of a resistant strain and treatment failure. We would like to emphasize the importance of high-dose DAP therapy for MRSA bacteremia, a condition with a potentially high mortality rate.

AB - We herein report a case of persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia that was successfully treated with combination therapy consisting of high-dose daptomycin (DAP, 10 mg/kg) and rifampicin. The patient’s condition was complicated with multiple infectious foci, including an iliopsoas abscess and epidural abscess, as well as discitis and spondylitis at the cervical, thoracic and lumbar levels. Monotherapy treatments with vancomycin, linezolid and usual-dose DAP were all ineffective. It has been shown that usual-dose DAP administration may result in the emergence of a resistant strain and treatment failure. We would like to emphasize the importance of high-dose DAP therapy for MRSA bacteremia, a condition with a potentially high mortality rate.

KW - Butyrylcholinesterase (BChE) deficiency

KW - Daptomycin (DAP)

KW - Methicillin-resistant Staphylococcus aureus (MRSA)

KW - Staphylococcus aureus bacteremia (SAB)

UR - http://www.scopus.com/inward/record.url?scp=84907459348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907459348&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.53.2711

DO - 10.2169/internalmedicine.53.2711

M3 - Article

C2 - 25224207

AN - SCOPUS:84907459348

VL - 53

SP - 2159

EP - 2163

JO - Internal Medicine

JF - Internal Medicine

SN - 0918-2918

IS - 18

ER -

Successful treatment of persistent MRSA bacteremia using high-dose daptomycin combined with rifampicin

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this